✦ LIBER ✦

A phase I/II study of antibody targeted therapy with CDP671/1 in advanced non-small cell lung cancer (NSCLC)

✍ Scribed by Lorigan, P; Carmichael, J; Woll, P.J; O'Byrne, K; Browne, S; Sopwith, M

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I/II study of Docetaxel (Taxoter

✍ Aamdal, S; Lauvvang, G; Owre, K; Hatlevoll, R; Armellini, J 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 98 KB

34 Phase II study of LY231514 in patient

✍ Clarke, S.; Boyer, M.; Millward, M.; Findlay, M.; Ackland, S.; Childs, A.; Brew, 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 161 KB

166 A phase II study of CI-980 in advanc

✍ Vokes, E.; Masters, G.; Mauer, A.; Klepsch, A.; Lad, T.; Ratain, M.; Sciortino, 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 164 KB

Phase I/II study of paclitaxel/vinorelbi

✍ Grunberg, S.M; Greenblatt, M; Ospina, D; Valentine, J 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 124 KB

Phase II study with paclitaxel in advanc

✍ Gatzemeier, U.; Pawel, J.v.; Heckmayer, M.; Neuhauss, R.; Schlüter, I. 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Oral etoposide preceding cisplatin in ad

✍ Focan, C.; Vandermoten, G.; Boossy, J.; Schallier, D. 📂 Article 📅 1988 🏛 Elsevier Science ⚖ 571 KB